ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,556, issued on April 14, was assigned to BIOTHERAVISION INC. (Chicago).
"Ophthalmic compositions" was invented by Roland Bodmeier (Berlin) and Chin-Ming Chang (Zhubei City, Taiwan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides an aqueous liquid composition for ophthalmic administration, comprising therapeutically effective amounts of a ketorolac compound and of a corticosteroid, wherein the ketorolac compound is present in an essentially dissolved form; wherein the corticosteroid is present in the form of suspended particles; and wherein the composition exhibits an acidic pH of about 6.5 or less. The invention further provide...